Spravato, a depression treatment derived from club drug ketamine, was looking like a dud. Its recent success now shows a path forward for psychedelic-based medicines.
Related Posts
Get Ready to Pay More for Less-Reliable Electricity
As the grid becomes increasingly unstable due to age and extreme weather, utilities are ramping up spending on long-overdue maintenance and capital improvements.
Auto & Transport Roundup: Market Talk
Read about Porsche SE, Rheinmetall, European defense companies and more in the latest Market Talks covering the Auto and Transport sector.
At Tesla, Musk Taps Close Confidant for Top Executive Role
Omead Afshar, who used to work in the office of the CEO, has moved into a vice president role with sales and manufacturing operations under […]